Does MOMETASONE FUROATE Cause Hyperlipidaemia? 41 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Hyperlipidaemia have been filed in association with MOMETASONE FUROATE (Mometasone Furoate). This represents 0.4% of all adverse event reports for MOMETASONE FUROATE.
41
Reports of Hyperlipidaemia with MOMETASONE FUROATE
0.4%
of all MOMETASONE FUROATE reports
11
Deaths
10
Hospitalizations
How Dangerous Is Hyperlipidaemia From MOMETASONE FUROATE?
Of the 41 reports, 11 (26.8%) resulted in death, 10 (24.4%) required hospitalization, and 10 (24.4%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMETASONE FUROATE. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does MOMETASONE FUROATE Cause?
No adverse event (3,717)
Product quality issue (3,406)
Poor quality device used (2,159)
Drug dose omission (2,005)
Dyspnoea (1,522)
Device malfunction (1,332)
Asthma (1,307)
Wheezing (1,142)
Cough (1,052)
Gastrooesophageal reflux disease (1,029)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which MOMETASONE FUROATE Alternatives Have Lower Hyperlipidaemia Risk?
MOMETASONE FUROATE vs MOMETASONE FUROATE\OLOPATADINE
MOMETASONE FUROATE vs MONOMETHYL
MOMETASONE FUROATE vs MONTELUKAST
MOMETASONE FUROATE vs MONTELUKAST\MONTELUKAST
MOMETASONE FUROATE vs MONTMORILLONITE